ArticleBioMed research international2025
Vocal Cord Dysfunction in Nonlaryngeal Head and Neck Cancer After Chemoradiation Therapy: Predictive Modeling Using CT Radiomics and Machine Learning.
Article in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Swin UNETR-based prediction of [BMC medical imaging · 2026Article
- Vocal Cord Dysfunction in Nonlaryngeal Head and Neck Cancer After Chemoradiation Therapy: Predictive Modeling Using CT Radiomics and Machine Learning.BioMed research international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aims to investigate computed tomography (CT) radiomic features and dosimetric-clinical biomarkers to predict vocal cord dysfunction (VCD) in nonlaryngeal head and neck cancer (HNC) patients treated with chemoradiation therapy (CRT), using machine learning (ML) models. Methods: Sixty-five HNC patients who underwent CRT were recruited to assess radiation-induced VCD 6 months posttreatment. For each patient, CT radiomic features of the laryngeal region, clinical, and dose-volume histogram (DVH) metrics were collected to develop ML models. Nine classifiers were trained using selected features obtained from three feature selection algorithms: least absolute shrinkage and selection operator (LASSO), extra trees, and elastic net. The models were built using imaging features alone (radiomics model) and in combination with clinical and dosimetric features (combined model). Model performance was evaluated using the area under the receiver operating characteristic curve (AUC-ROC). Results: Of the 65 patients, 31 developed VCD. Among radiomics models, the AdaBoost and random forest (RF) classifiers performed best, with AUCs of 0.74 and 0.84, respectively. For the combined models, nine classifiers achieved an AUC greater than 0.95 using LASSO and elastic net algorithms. In contrast, only one classifier surpassed an AUC of 0.95 when using the extra trees algorithm. Conclusion: Our findings demonstrate that pretreatment CT radiomic features are predictive biomarkers for radiation-induced toxicities, including VCD. Furthermore, combining radiomic features with clinical and dosimetric data can improve the predictive modeling of radiotherapy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.